Lipocine (LPCN) Change in Cash (2011 - 2025)

Lipocine (LPCN) has 15 years of Change in Cash data on file, last reported at -$2.1 million in Q3 2025.

• Quarterly Change in Cash fell 18.37% year-over-year to -$2.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $158099.0 (up 147.94% YoY) and the FY2024 annual result came in at $1.4 million, down 11.65% from the prior year.
• Change in Cash eased to -$2.1 million in Q3 2025, from $2.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.8 million in Q1 2022 to a low of -$8.6 million in Q1 2021.
• A 5-year average of -$1.1 million and a median of -$941989.0 in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2021 — Change in Cash sank 617.03% — and 2024, when it surged 906.88%.
• Tracing LPCN's Change in Cash over 5 years: stood at -$1.6 million in 2021, then soared by 147.97% to $751536.0 in 2022, then decreased by 6.98% to $699052.0 in 2023, then jumped by 252.33% to $2.5 million in 2024, then sank by 187.01% to -$2.1 million in 2025.
• The last three Change in Cash figures came in at -$2.1 million (Q3 2025), $2.7 million (Q2 2025), and -$2.9 million (Q1 2025), per Business Quant data.